Men's Health News

Roughly one-third of men globally have at least one type of genital HPV and one in five are infected with at least one high-risk HPV type, according to the results of a systematic review and meta-analysis.

After age 70 years, researchers found that having a higher BMI and the presence of certain conditions such as diabetes and cancer were associated with lower testosterone concentrations.

Researchers reported finding lower testosterone levels among middle-aged men and women with excessive sleep as well as middle-aged women with inadequate sleep compared with those who slept 7 to 8 hours each night.

People with HIV diagnosed with mpox were not at an increased risk for hospitalization unless they were immunosuppressed, according to findings presented at the International AIDS Society Conference on HIV Science.

Voluntary medical male circumcision can reduce the risk for HIV acquisition among men who have sex with men who primarily practice insertive anal sex, according to the results of a randomized controlled trial conducted in China.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the role of hormone blocking therapies in prostate cancer care.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the role of hormone blocking therapies in prostate cancer care.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses disparities in care that exist in the treatment of prostate cancer.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses risk factors for prostate cancer.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the latest developments in prostate cancer treatment.